Three Different Locations of a Sentinel Node Highlight the Importance of Performing a Sentinel Node Biopsy in Breast Cancer Recurrence.

Adrien Albert, Ivan Huyghe, Sigrid Stroobants, Wiebren A A Tjalma

Open access · goldAbstract readCase Reports

In one paragraph

Article in Breast cancer : basic and clinical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.4field-weighted citation impact, top 36% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Adrien AlbertUniversity Multidisciplinary Breast Clinic Antwerpen, Antwerp University Hospital-University of Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital-University of Antwerp, Belgium.

Ivan HuygheUniversity Multidisciplinary Breast Clinic Antwerpen, Antwerp University Hospital-University of Antwerp, Belgium.; Department of Nuclear Medicine, Antwerp University Hospital-University of Antwerp, Belgium.

Sigrid StroobantsDepartment of Nuclear Medicine, Antwerp University Hospital-University of Antwerp, Belgium.

Wiebren A A TjalmaUniversity Multidisciplinary Breast Clinic Antwerpen, Antwerp University Hospital-University of Antwerp, Belgium.

Antwerp University Hospital · BEUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A local breast cancer recurrence or a new breast cancer in the previously treated breast is a staging challenge. Staging is important to tailor the local and the systemic treatment. Earlier treatment(s) can disrupt the primary lymphatic drainage. After the disruption, new lymphatic drainage pathways are often created. The identification of these new pathways together with their sentinel node(s) (SN) is important for retreatment. A fluorodeoxyglucose positron emission tomography-computerized tomography could be useful to identify the involved node(s), but, unfortunately, there is no evidence to support this. Ideally, in the case of a recurrence, an SN biopsy should be performed in order to identify the "new" draining lymph node(s). This new draining SN(s) can be located in unexpected places, and tumor invasion will lead to a change in the management.

Indexed as

biopsybreast cancerradionuclide imagingrecurrencesentinel nodetreatment

Identifiers

PMID26792995

DOI10.4137/BCBCR.S30471

PMCPMC4711390

OpenAlexW2234276433

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.